About Caribou Biosciences, Inc. 
Caribou Biosciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 43 Schemes (17.5%)
Foreign Institutions
Held by 65 Foreign Institutions (8.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Dec 2025)
Net Profit:
-26 Million
Pharmaceuticals & Biotechnology
USD 181 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.02
-96.46%
1.27






